Profusa

aid: profusa
name: Profusa
description: 'Profusa, Inc. (Nasdaq: PFSA) is a South San Francisco digital-health and medical-device company that builds
  tissue-integrated biosensors — injectable, biologically compatible hydrogel microsensors smaller than a grain of rice —
  for continuous, real-time monitoring of body chemistry. Its Lumee Oxygen Platform reports tissue oxygen for peripheral artery
  disease, chronic wounds and reconstructive surgery, and a long-duration Lumee glucose sensor is in development. A companion
  Data Platform turns raw sensor readings into clinical intelligence for clinicians, with EMR integration described as planned
  rather than shipped. Profusa has received more than USD 23M in NIH and DARPA funding and became publicly traded in July
  2025 through a business combination with NorthView Acquisition Corporation. As of this profiling pass the company publishes
  no developer program, no public API documentation and no machine-readable API contract.'
url: https://raw.githubusercontent.com/api-evangelist/profusa/refs/heads/main/apis.yml
x-api-posture: no-product-api
x-api-posture-basis: observed
x-api-posture-note: As of this profiling pass the company publishes no developer program, no public API documentation and
  no machine-readable API contract.
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  gated: private
  gated_source:
  - x-api-posture
  label: Unknown
  confidence: low
  probe_state: none
  source:
  - security
  generated: '2026-11-06'
  method: derived
image: https://profusa.com/wp-content/uploads/2015/12/cropped-profusa-logo-1-270x270.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Health
- Medical Devices
- Biosensors
- Digital Health
- Continuous Monitoring
- Diagnostics
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/profusa-domain-security.yml
- type: Website
  url: https://profusa.com/
- type: About
  url: https://profusa.com/about-profusa/
- type: Support
  url: https://profusa.com/contact-profusa/
- type: Blog
  url: https://investors.profusa.com/press-releases
- type: BlogRSS
  url: https://profusa.com/feed/
- type: Careers
  url: https://profusa.com/careers-profusa/
- type: InvestorRelations
  url: https://investors.profusa.com/
- type: LinkedIn
  url: https://www.linkedin.com/company/profusa
- type: LLMsTxt
  url: llms/profusa-llms.txt
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: no-developer-program
  detail: Profusa ships a clinical Data Platform and a phone app for its Lumee biosensors but publishes nothing for developers
    — profusa.com is a WordPress marketing site whose only machine-readable surface is the generic WordPress core REST discovery
    document at /wp-json/, and every developer path (/developers, /api, /docs, /openapi.json, /llms.txt, /.well-known/*) returns
    404, while investors.profusa.com answers 200 with an SPA shell for every path including /.well-known/agent-card.json.
  evidence:
  - url: https://profusa.com/developers
    status: 404
  - url: https://profusa.com/openapi.json
    status: 404
  - url: https://profusa.com/llms.txt
    status: 404
  - url: https://profusa.com/.well-known/agent-card.json
    status: 404
  - url: https://profusa.com/wp-json/
    status: 200
  - url: https://investors.profusa.com/.well-known/agent-card.json
    status: 200
  checked: '2026-08-26'